Berger Montague, a prominent securities litigation firm, has launched an investigation into Hims & Hers Health, Inc. (NYSE: HIMS) after the company's stock plummeted by more than 26% in a single day. This dramatic fall occurred on June 23, coinciding with the sudden termination of Hims & Hers' partnership with pharmaceutical giant Novo Nordisk.

Novo Nordisk accused Hims & Hers of engaging in deceptive marketing practices and distributing unapproved compounded versions of semaglutide, a key component in popular GLP-1 drugs like Wegovy and Ozempic. Following these allegations, Hims & Hers, a telehealth company that recently ventured into the GLP-1 weight loss drug market, faces scrutiny over how it sourced and marketed these treatments.

The investigation by Berger Montague focuses on whether Hims & Hers and its executives failed to adequately disclose several critical issues to investors. These include potential regulatory concerns regarding the compounded semaglutide, the inherent risks of their GLP-1 drug offerings, and the specifics of their partnership with Novo Nordisk.

Investors who purchased HIMS stock and suffered losses due to the June 23 stock crash may have legal recourse. Those affected are encouraged to learn more about their options by visiting Berger Montague’s dedicated investigation page.

For direct inquiries, potential claimants can reach out to Andrew Abramowitz at [email protected] or by phone at (215) 875-3015, and Peter Hamner at [email protected].

Hims & Hers Health, Inc., established in 2017 and headquartered in San Francisco, California, is a publicly traded company that provides a wide range of telehealth services across the U.S. and UK. These services address issues such as sexual health, hair loss, dermatology, mental health, and weight management. The company, which went public in 2021 following a SPAC merger, emphasizes accessible, stigma-free, and affordable care, boasting over 1.5 million subscribers. It has also expanded internationally by acquiring the UK-based telehealth provider ZAVA.

Berger Montague, founded in 1970 and based in Philadelphia, Pennsylvania, specializes in complex litigation, including class actions, antitrust matters, and consumer protection cases. The firm has built a reputation for securing significant legal victories and recovering billions of dollars for consumers, investors, and employees across high-profile lawsuits. With a robust team of experienced attorneys, Berger Montague continues to champion the rights of its clients through dedicated and strategic legal practices.